-

The words GOP presidential hopefuls use to stand out in a crowded field
We analyzed each major candidate’s intro speech to voters, finding former President Donald Trump is still driving what Republicans talk about, Gov. Ron DeSantis is doubling down on his track record in Florida and, in a diverse presidential field, candidates of color are in a unique position to talking about racism in America.
-

Embracing ‘Bidenomics,’ Biden seeks to turn an insult into a strength
Adoption of conservative barb, to be highlighted in a speech Wednesday, reflects a decision to own the economy for better or worse.
-

It’s not just Mar-a-Lago: Trump charges highlight his New Jersey life
Two of the most vivid scenes in the former president’s indictment take place at his Bedminster golf club, which has not been searched by the FBI.
-

Russian General Knew About Mercenary Chief’s Rebellion Plans, U.S. Officials Say
Yevgeny Prigozhin, the head of Wagner, may have believed he had support in Russia’s military.
-

McCarthy Questions Strength of Trump’s Candidacy, Then Quickly Backtracks
The House speaker angered Donald J. Trump’s allies by saying he did not know whether the former president was the strongest candidate to beat President Biden.
-

Biden to Deliver Major Address on the Economy in Chicago
President Biden hopes to claim credit for what the White House describes as a record-breaking economic revival in America.
-

Competing Accounts of Justice Dept.’s Handling of Hunter Biden Case
An I.R.S. investigator’s testimony describing strains over the inquiry into President Biden’s son is at odds with the version laid out by Attorney General Merrick Garland.
-

Religious Freedom Arguments Underpin Wave of Challenges to Abortion Bans
In lawsuits challenging state abortion bans, lawyers for abortion rights plaintiffs are employing religious liberty arguments the Christian right has used for decades.
-

FDA Issues First Guidance on Clinical Trials for Psychedelic Drugs
The U.S. Food and Drug Administration (FDA or Agency) on June 23, 2023, released its first draft guidance concerning design and desired features of clinical trials for psychedelic drugs LSD and MDMA There has been growing interest in studying the use of psychedelic drugs for patients with conditions such as treatment-resistant depression, substance-use disorders and……By:…
-

Congress’ latest attempt to address subject matter eligibility
Through the vicissitudes of the continuing chaos of subject matter eligibility, Senators Coons and Tillis have been steadfast in attempting to provide a legislative solution. They chaired a series of Congressional hearings in 2019 and have proposed several bills providing various iterations of these solutions. This week, they co-sponsored their latest attempt, entitled “The Patent…